Stocksigma LogoStocksigma Logo

Sun Pharma Board to Consider Raising up to INR 15,000 Crore via NCDs

Sun Pharmaceutical Industries Limited has scheduled a Board of Directors meeting on 12th Oct'26 to consider and approve the issuance of listed, rated

Sun Pharma Board to Consider Raising up to INR 15,000 Crore via NCDs

Sun Pharmaceutical Industries Ltd 路 Intimation 路 08 Oct 2026, 2:09 am

Sun Pharma Board to Consider Raising up to INR 15,000 Crore via NCDs Sun Pharmaceutical Industries Limited has scheduled a Board of Directors meeting on 12th Oct'26 to consider and approve the issuance of listed, rated, unsecured, redeemable non-convertible debentures (NCDs). The planned fundraise will be executed in one or more tranches on a private placement basis for an aggregate amount not exceeding INR 15,000 Crore.

Original exchange filing (PDF)

More announcements from Sun Pharmaceutical Industries Ltd

All Sun Pharmaceutical Industries Ltd announcements